AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36111911 — intervention group
Group type: COMPARATOR
Intervention: Ordinary tap water baths (same regimen as study group)
Number of subjects: 40
Study 32065032 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT)
Number of subjects: 13
Study 35724774 — intervention group
Group type: EXPERIMENTAL
Intervention: Xerostomia and trismus data
Number of subjects: 0
Study 33726830 — intervention group
Group type: EXPERIMENTAL
Intervention: ASPIRE intervention (a four-session blended multi-component counselling intervention)
Number of subjects: 100
Study 33726830 — intervention group
Group type: EXPERIMENTAL
Intervention: ASPIRE intervention
Number of subjects: 100
Study 33726830 — intervention group
Group type: COMPARATOR
Intervention: Comparison condition (not specified)
Number of subjects: 100
Study 33415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting elder abuse or neglect against their elderly parents
Number of subjects: 7466
Study 33415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Instances of abuse and neglect reported by participants
Number of subjects: 7466
Study 33415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting multiple types of abuse and neglect
Number of subjects: 7466
Study 33415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-occurrence of elder abuse within elderly couples
Number of subjects: 7466
Study 33415994 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of elder abuse and neglect with socioeconomic and contextual factors
Number of subjects: 7466
Study 33434727 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based group therapy (MBGT) + Treatment-as-usual (TAU)
Number of subjects: 40
Study 33434727 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 40
Study 36384950 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based education and peer support programme led by women's self-help group members; assistance in daily hypertension management, social and emotional support, referral to primary healthcare system.
Number of subjects: 1952
Study 36384950 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control arm).
Number of subjects: 1952
Study 32112593 — intervention group
Group type: EXPERIMENTAL
Intervention: Media-based recruitment
Number of subjects: 168
Study 32112593 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face recruitment
Number of subjects: 168
Study 35197411 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 85
Study 35197411 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 85
Study 35197411 — intervention group
Group type: EXPERIMENTAL
Intervention: High aerobic with low resistance training (HALRT)
Number of subjects: 85
Study 35197411 — intervention group
Group type: EXPERIMENTAL
Intervention: High resistance with low aerobic training (HRLAT)
Number of subjects: 85
Study 35197411 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 85
Study 33207300 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke awareness assessment through a questionnaire
Number of subjects: 144
Study 32315289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric infusion of glucose
Number of subjects: 76
Study 32315289 — intervention group
Group type: COMPARATOR
Intervention: Intragastric infusion of water
Number of subjects: 76
Study 32315289 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of peripheral appetite hormones
Number of subjects: 76
Study 616543714 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy student-created podcasts
Number of subjects: 29
Study 34281042 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR_PPE
Number of subjects: 20
Study 34281042 — intervention group
Group type: COMPARATOR
Intervention: CPR_control
Number of subjects: 20
Study 33048034 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial transit artifacts (ATAs) in participants with greater than 70% stenosis (16 of 28 patients)
Number of subjects: 44
Study 33048034 — intervention group
Group type: COMPARATOR
Intervention: Degree of stenosis (≥70% vs <70%)
Number of subjects: 44
Study 33048034 — intervention group
Group type: COMPARATOR
Intervention: Intraplaque hemorrhage (IPH) presence
Number of subjects: 44
Study 33048034 — intervention group
Group type: COMPARATOR
Intervention: Plaque surface structure (irregular/ulcerated vs smooth)
Number of subjects: 44
Study 33048034 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of arterial transit artifacts (ATAs)
Number of subjects: 44
Study 34049538 — intervention group
Group type: EXPERIMENTAL
Intervention: New two-year residency program
Number of subjects: 0
Study 34049538 — intervention group
Group type: COMPARATOR
Intervention: Traditional one-year family medicine residency program
Number of subjects: 0
Study 35380374 — intervention group
Group type: EXPERIMENTAL
Intervention: ON-SXB 6 g
Number of subjects: 190
Study 35380374 — intervention group
Group type: EXPERIMENTAL
Intervention: ON-SXB 7.5 g
Number of subjects: 190
Study 35380374 — intervention group
Group type: EXPERIMENTAL
Intervention: ON-SXB 9 g
Number of subjects: 190
Study 33515859 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnastics program
Number of subjects: 50
Study 33515859 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 50
Study 32022679 — intervention group
Group type: EXPERIMENTAL
Intervention: SC+CBSC
Number of subjects: 250
Study 32022679 — intervention group
Group type: COMPARATOR
Intervention: SC
Number of subjects: 250
Study 36216727 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg of remifentanil dissolved in 25 ml of saline
Number of subjects: 60
Study 36216727 — intervention group
Group type: COMPARATOR
Intervention: 25 ml of intra‐articular normal saline
Number of subjects: 60
Study 34126097 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial needling acupuncture
Number of subjects: 86
Study 34126097 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 86
Study 34126097 — intervention group
Group type: COMPARATOR
Intervention: Difference between acupuncture and sham
Number of subjects: 86
Study 34126097 — intervention group
Group type: COMPARATOR
Intervention: Difference between groups at week 10
Number of subjects: 86
Study 34126097 — intervention group
Group type: COMPARATOR
Intervention: Western Ontario and McMaster Universities Osteoarthritis Index
Number of subjects: 86
Study 34126097 — intervention group
Group type: COMPARATOR
Intervention: 36-Item Short Form Health Survey
Number of subjects: 86
Study 34126097 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 86
Study 36316939 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine-based rehabilitation nursing combined with scalp acupuncture (TCMRN + SA)
Number of subjects: 102
Study 36316939 — intervention group
Group type: COMPARATOR
Intervention: Traditional Chinese medicine-based rehabilitation nursing (TCMRN)
Number of subjects: 102
Study 35677618 — intervention group
Group type: EXPERIMENTAL
Intervention: Siddha medicine preparation (Nochi Kudineer Chooranam 5 gm, Mahasudarsan Chooranam 3 gm, Adathodai Manapagu 10 ml, Omatheeneer 10 ml, Maldevi chenduram 100 mg with honey) for 7 days
Number of subjects: 100
Study 35677618 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: PanCan-1b model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: PanCan-2b model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: PanCan-MD model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: PanCan-VOL model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: UK Lung Cancer Screening trial model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: Mayo Clinic model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: Peking University People's Hospital model
Number of subjects: 1159
Study 32058555 — intervention group
Group type: EXPERIMENTAL
Intervention: Department of Veterans Affairs model
Number of subjects: 1159
Study 35973732 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower (worse) secretion scores at baseline
Number of subjects: 2089
Study 35973732 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower secretion score
Number of subjects: 2089
Study 34653721 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Anesthetic Injection (LAI)
Number of subjects: 160
Study 34653721 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 160
Study 34653721 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal Local Anesthetic Injection (IPLA)
Number of subjects: 160
Study 34653721 — intervention group
Group type: COMPARATOR
Intervention: Control group (no local anesthetic)
Number of subjects: 160
Study 32601985 — intervention group
Group type: COMPARATOR
Intervention: Placebo–placebo
Number of subjects: 161
Study 32601985 — intervention group
Group type: COMPARATOR
Intervention: Placebo–propranolol
Number of subjects: 161
Study 32601985 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone–placebo
Number of subjects: 161
Study 32601985 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone–propranolol
Number of subjects: 161
Study 35404295 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory processing speed training (40 hours over 13 weeks)
Number of subjects: 18
Study 35404295 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 18
Study 35404295 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory processing speed training
Number of subjects: 18
Study 34862871 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (Group I)
Number of subjects: 200
Study 34862871 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib (Group II)
Number of subjects: 200
Study 34862871 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human endostatin (Group III)
Number of subjects: 200
Study 34862871 — intervention group
Group type: COMPARATOR
Intervention: Control group (no targeted drug)
Number of subjects: 200
Study 35587019 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged use of aprepitant (PA; 6‐day aprepitant)
Number of subjects: 0
Study 35587019 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard use of aprepitant (SA; 3‐day aprepitant)
Number of subjects: 0
Study 35587019 — intervention group
Group type: COMPARATOR
Intervention: Control group (C; patients who rejected aprepitant)
Number of subjects: 0
Study 33781388 — intervention group
Group type: EXPERIMENTAL
Intervention: PDCA management of central venous catheter
Number of subjects: 244
Study 33781388 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 244
Study 33582682 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine (N=36)
Number of subjects: 102
Study 33582682 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetrizine (N=37)
Number of subjects: 102
Study 33582682 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (N=29)
Number of subjects: 102
Study 35313949 — intervention group
Group type: EXPERIMENTAL
Intervention: treatment-as-usual + AppBM
Number of subjects: 336
Study 35313949 — intervention group
Group type: COMPARATOR
Intervention: treatment-as-usual + Sham
Number of subjects: 336
Study 35313949 — intervention group
Group type: COMPARATOR
Intervention: treatment-as-usual only
Number of subjects: 336
Study 35533225 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride Varnish (FV) applied at three points
Number of subjects: 0
Study 35533225 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what the control was)
Number of subjects: 0
Study 34590936 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete visual occlusion
Number of subjects: 60
Study 34590936 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower visual field visual occlusion
Number of subjects: 60
Study 34590936 — intervention group
Group type: COMPARATOR
Intervention: Normal vision
Number of subjects: 60
Study 35277340 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine plus paracetamol
Number of subjects: 0
Study 35277340 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine plus morphine (control)
Number of subjects: 0
Study 33693920 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted serum iron status
Number of subjects: 4036
Study 33693920 — intervention group
Group type: EXPERIMENTAL
Intervention: Log-transformed ferritin
Number of subjects: 4036
Study 33693920 — intervention group
Group type: EXPERIMENTAL
Intervention: Transferrin saturation
Number of subjects: 4036
Study 33693920 — intervention group
Group type: EXPERIMENTAL
Intervention: Transferrin
Number of subjects: 4036
Study 32493460 — intervention group
Group type: EXPERIMENTAL
Intervention: CoVideo (E-E video about COVID-19 hygiene)
Number of subjects: 20100
Study 32493460 — intervention group
Group type: COMPARATOR
Intervention: APC video (attention placebo control video)
Number of subjects: 20100
Study 32493460 — intervention group
Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 20100
Study 36058804 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic Diagnosis-guided Laser Photocoagulation of Bladder Tumor (PC-BT) in outpatient department using a 980 nm diode laser
Number of subjects: 176
Study 36058804 — intervention group
Group type: COMPARATOR
Intervention: Transurethral Resection of Bladder Tumor (TUR-BT) in general anesthesia
Number of subjects: 176
Study 32835826 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid treatment
Number of subjects: 0
Study 32835826 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative analgesic agents
Number of subjects: 0
Study 32737760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous thoracic paravertebral block (TPVB) in group T
Number of subjects: 150
Study 32737760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous thoracic paravertebral block (TPVB) in group P
Number of subjects: 150
Study 32737760 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural analgesia in group E
Number of subjects: 150
Study 32737760 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (T, P, E)
Number of subjects: 150
Study 32453396 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA (465 mg) plus vitamin E (600 IU)
Number of subjects: 180
Study 32453396 — intervention group
Group type: COMPARATOR
Intervention: DHA (465 mg) plus placebo
Number of subjects: 180
Study 32453396 — intervention group
Group type: COMPARATOR
Intervention: 600 IU vitamin E plus placebo
Number of subjects: 180
Study 32453396 — intervention group
Group type: COMPARATOR
Intervention: Both placebo capsules
Number of subjects: 180
Study 33431087 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 576
Study 33431087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study 34465716 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone combined with gelatin sponge (test group, n=28)
Number of subjects: 54
Study 34465716 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone (control group, n=26)
Number of subjects: 54
Study 33389719 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction (FA) symptom criteria met
Number of subjects: 83
Study 33389719 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction (FA) symptom criteria not met
Number of subjects: 83
Study 33389719 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Addiction (FA) symptom criteria met but not impairment/distress
Number of subjects: 83
Study 33389719 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of age at onset of overweight
Number of subjects: 83
Study 35603411 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) 70 mL (400 mg of nitrate)
Number of subjects: 14
Study 32295483 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) programme for 12 weeks, 45 min twice a week
Number of subjects: 147
Study 32295483 — intervention group
Group type: COMPARATOR
Intervention: Control group (day care as usual)
Number of subjects: 147
Study 32274500 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Cancer‐Related Insomnia (BBT‐CI)
Number of subjects: 74
Study 32274500 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene pamphlet (control)
Number of subjects: 74
Study 35152531 — intervention group
Group type: COMPARATOR
Intervention: 5% minoxidil
Number of subjects: 40
Study 34107473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 800 IE/day for 12 weeks (healthy individuals)
Number of subjects: 136
Study 34107473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol adapted to serum levels for 12 weeks (hemodialysis patients)
Number of subjects: 136
Study 34107473 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks (healthy individuals)
Number of subjects: 136
Study 34107473 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks (hemodialysis patients)
Number of subjects: 136
Study 32621465 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigational dual-target high-frequency rTMS (10 Hz) applied over the primary motor cortex (M1) and left dorsolateral prefrontal cortex (DLPFC) for 20 daily sessions over 3 weeks.
Number of subjects: 46
Study 32621465 — intervention group
Group type: COMPARATOR
Intervention: Placebo rTMS (10 Hz) applied over the same areas for 20 daily sessions over 3 weeks.
Number of subjects: 46
Study 34633666 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh RBC transfusions (≤7 days)
Number of subjects: 40
Study 34633666 — intervention group
Group type: EXPERIMENTAL
Intervention: Old RBC transfusions (≥21 days)
Number of subjects: 40
Study 34633666 — intervention group
Group type: COMPARATOR
Intervention: Stored RBC transfusion in mice with immune hemolysis
Number of subjects: 40
Study 34633666 — intervention group
Group type: COMPARATOR
Intervention: Stored RBC transfusion in mice with ITP
Number of subjects: 40
Study 32937023 — intervention group
Group type: EXPERIMENTAL
Intervention: telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg
Number of subjects: 202
Study 32937023 — intervention group
Group type: COMPARATOR
Intervention: telmisartan 80 mg + rosuvastatin 20 mg
Number of subjects: 202
Study 32937023 — intervention group
Group type: COMPARATOR
Intervention: telmisartan/amlodipine 80/5 mg
Number of subjects: 202
Study 32370544 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HI‐AIT & IMT
Number of subjects: 40
Study 32370544 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 34731917 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 402
Study 34731917 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 402
Study 32125718 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue expander
Number of subjects: 46
Study 32125718 — intervention group
Group type: COMPARATOR
Intervention: Conventional vertical GBR
Number of subjects: 46
Study 35871600 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + CCM + rhPDGF
Number of subjects: 30
Study 35871600 — intervention group
Group type: COMPARATOR
Intervention: CAF + CCM + saline
Number of subjects: 30
Study 33721444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab combined with IMRT and concurrent cisplatin‐based chemotherapy
Number of subjects: 126
Study 33721444 — intervention group
Group type: COMPARATOR
Intervention: IMRT combined with concurrent cisplatin‐based chemotherapy (Control group)
Number of subjects: 126
Study 35750460 — intervention group
Group type: EXPERIMENTAL
Intervention: Bearberry (dry extract of Uvae ursi folium)
Number of subjects: 504
Study 35750460 — intervention group
Group type: COMPARATOR
Intervention: Fosfomycin (3 g single dose) and two placebo tablets three times a day for 7 days
Number of subjects: 504
Study 33124762 — intervention group
Group type: EXPERIMENTAL
Intervention: ELLIPTA dry-powder inhaler (DPI)
Number of subjects: 222
Study 33938936 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab-Ipilimumab combination therapy
Number of subjects: 0
Study 34817540 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with intensive lower extremity resistance training (RT) 3 times per week over 12 weeks
Number of subjects: 56
Study 34817540 — intervention group
Group type: COMPARATOR
Intervention: Standard moderate intensity continuous training (MCT) with moderate intensive RT
Number of subjects: 56
Study 34817540 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training with resistance training (HIIT-RT)
Number of subjects: 56
Study 34817540 — intervention group
Group type: COMPARATOR
Intervention: Standard CR exercise training
Number of subjects: 56
Study 32366948 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori (Hp) sero-positivity with periodontal pathogens (e.g., Prevotella intermedia, Campylobacter Rectus, Actinomyces Naeslundii)
Number of subjects: 1431
Study 32366948 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of Actinomyces Naeslundii (An)
Number of subjects: 1431
Study 32366948 — intervention group
Group type: EXPERIMENTAL
Intervention: Fusobacterim nucleatum (Fn) and Factor 1 (including Fn)
Number of subjects: 1431
Study 32366948 — intervention group
Group type: EXPERIMENTAL
Intervention: Probing depth and clinical attachment loss (CAL)
Number of subjects: 1431
Study 32366948 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected periodontal pathogen titers, factors, and clusters
Number of subjects: 1431
Study 33186193 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum 3 times a day for 45 minutes after removal of nasogastric tubes until first flatus;
Number of subjects: 34
Study 33186193 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control);
Number of subjects: 34
Study 35394395 — intervention group
Group type: EXPERIMENTAL
Intervention: IC ECG
Number of subjects: 344
Study 35394395 — intervention group
Group type: COMPARATOR
Intervention: Traditional CVAD insertion
Number of subjects: 344
Study 34610254 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% dosed twice daily
Number of subjects: 121
Study 34610254 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% dosed nightly
Number of subjects: 121